Breast cancer is a heterogeneous disease that includes a particular subtype, the triple negative breast cancer (TNBC) subtype, characterized by lack of immunohistochemistry (IHC) staining for estrogen receptor (ER), progesterone receptor (PR), and HER2 receptors1. Here, PGR is linked to breast cancer.